Acrivon Therapeutics, Inc.·4

Aug 16, 4:53 PM ET

Peterson Katharine 4

4 · Acrivon Therapeutics, Inc. · Filed Aug 16, 2024

Insider Transaction Report

Form 4
Period: 2024-08-14
Peterson Katharine
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2024-08-14$7.02/sh99$6954,634 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file
  • 4
    form4.xmlPrimary